145 related articles for article (PubMed ID: 15665364)
1. Systemic FK506 improved tear secretion in dry eye associated with chronic graft versus host disease.
Aoki S; Mizote H; Minamoto A; Suzuki M; Mishima HK; Tanaka H
Br J Ophthalmol; 2005 Feb; 89(2):243-4. PubMed ID: 15665364
[No Abstract] [Full Text] [Related]
2. Efficacy of topical cyclosporine 0.05% in the treatment of dry eye associated with graft versus host disease.
Rao SN; Rao RD
Cornea; 2006 Jul; 25(6):674-8. PubMed ID: 17077659
[TBL] [Abstract][Full Text] [Related]
3. Topical cyclosporine-A in dry eye associated with chronic graft versus host disease.
Kurt RA; Yalçindag N; Atilla H; Arat M
Ann Ophthalmol (Skokie); 2009; 41(3-4):166-9. PubMed ID: 20214049
[TBL] [Abstract][Full Text] [Related]
4. Ocular surface and tear functions after topical cyclosporine treatment in dry eye patients with chronic graft-versus-host disease.
Wang Y; Ogawa Y; Dogru M; Kawai M; Tatematsu Y; Uchino M; Okada N; Igarashi A; Kujira A; Fujishima H; Okamoto S; Shimazaki J; Tsubota K
Bone Marrow Transplant; 2008 Feb; 41(3):293-302. PubMed ID: 17982500
[TBL] [Abstract][Full Text] [Related]
5. Topical tranilast for treatment of the early stage of mild dry eye associated with chronic GVHD.
Ogawa Y; Dogru M; Uchino M; Tatematsu Y; Kamoi M; Yamamoto Y; Ogawa J; Ishida R; Kaido M; Hara S; Matsumoto Y; Kawakita T; Okamoto S; Tsubota K
Bone Marrow Transplant; 2010 Mar; 45(3):565-9. PubMed ID: 19633693
[TBL] [Abstract][Full Text] [Related]
6. [A 0,05% cyclosporine treatment of the advanced dry eye syndrome].
Kujawa A; Rózycki R
Klin Oczna; 2005; 107(4-6):280-6. PubMed ID: 16118939
[TBL] [Abstract][Full Text] [Related]
7. The scientific context and basis of the pharmacologic management of dry eyes.
Gilbard JP
Ophthalmol Clin North Am; 2005 Dec; 18(4):475-84, v. PubMed ID: 16314213
[TBL] [Abstract][Full Text] [Related]
8. Treatment of refractory dry eye associated with graft versus host disease with 0.03% tacrolimus eyedrops.
Sanz-Marco E; Udaondo P; García-Delpech S; Vazquez A; Diaz-Llopis M
J Ocul Pharmacol Ther; 2013 Oct; 29(8):776-83. PubMed ID: 23947579
[TBL] [Abstract][Full Text] [Related]
9. Topical 0.03% tacrolimus ointment in the management of ocular surface inflammation in chronic GVHD.
Tam PM; Young AL; Cheng LL; Lam PT
Bone Marrow Transplant; 2010 May; 45(5):957-8. PubMed ID: 19802037
[No Abstract] [Full Text] [Related]
10. Extended-wear silicone hydrogel soft contact lenses in the management of moderate to severe dry eye signs and symptoms secondary to graft-versus-host disease.
Russo PA; Bouchard CS; Galasso JM
Eye Contact Lens; 2007 May; 33(3):144-7. PubMed ID: 17502749
[TBL] [Abstract][Full Text] [Related]
11. Long-term resolution of chronic dry eye symptoms and signs after topical cyclosporine treatment.
Wilson SE; Perry HD
Ophthalmology; 2007 Jan; 114(1):76-9. PubMed ID: 17070588
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic effect of umbilical cord serum eyedrops for the treatment of dry eye associated with graft-versus-host disease.
Yoon KC; Jeong IY; Im SK; Park YG; Kim HJ; Choi J
Bone Marrow Transplant; 2007 Feb; 39(4):231-5. PubMed ID: 17211430
[TBL] [Abstract][Full Text] [Related]
13. Allogeneic serum eye drops for the treatment of severe dry eye in patients with chronic graft-versus-host disease.
Chiang CC; Lin JM; Chen WL; Tsai YY
Cornea; 2007 Aug; 26(7):861-3. PubMed ID: 17667623
[TBL] [Abstract][Full Text] [Related]
14. Long-term efficacy of topical tacrolimus on oral lesions of chronic graft-versus-host disease.
Fricain JC; Sibaud V; Swetyenga N; Tabrizi R; Campana F; Taïeb A
Br J Dermatol; 2007 Mar; 156(3):588-90. PubMed ID: 17300261
[No Abstract] [Full Text] [Related]
15. Ophthalmic cyclosporine use in ocular GVHD.
Lelli GJ; Musch DC; Gupta A; Farjo QA; Nairus TM; Mian SI
Cornea; 2006 Jul; 25(6):635-8. PubMed ID: 17077652
[TBL] [Abstract][Full Text] [Related]
16. Successful treatment of dry eye in two patients with chronic graft-versus-host disease with systemic administration of FK506 and corticosteroids.
Ogawa Y; Okamoto S; Kuwana M; Mori T; Watanabe R; Nakajima T; Yamada M; Mashima Y; Tsubota K; Oguchi Y
Cornea; 2001 May; 20(4):430-4. PubMed ID: 11333336
[TBL] [Abstract][Full Text] [Related]
17. [Graft versus host disease following liver transplantation. Favorable outcome after treatment with tacrolimus].
Dumortier J; Souraty P; Bernard P; Scoazec JY; Berger F; Euvrard S; Boillot O
Gastroenterol Clin Biol; 2003 May; 27(5):561-2. PubMed ID: 12843926
[No Abstract] [Full Text] [Related]
18. Successful use of topical retinoic acid in severe dry eye due to chronic graft-versus-host disease.
Murphy PT; Sivakumaran M; Fahy G; Hutchinson RM
Bone Marrow Transplant; 1996 Sep; 18(3):641-2. PubMed ID: 8879631
[TBL] [Abstract][Full Text] [Related]
19. [Tacrolimus ointment in the treatment of chronic cutaneous graft-versus-host disease].
Firmin D; Karam A; Guillerm G; Roguedas AM; Berthou C; Misery L
Ann Dermatol Venereol; 2008 Mar; 135(3):234-6. PubMed ID: 18374862
[No Abstract] [Full Text] [Related]
20. Safety and efficacy of cyclosporine 0.05% drops versus unpreserved artificial tears in dry-eye patients having laser in situ keratomileusis.
Salib GM; McDonald MB; Smolek M
J Cataract Refract Surg; 2006 May; 32(5):772-8. PubMed ID: 16765793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
